admin, Author at Integral Molecular

Published by

Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response

GODOY-LOZANO ET AL. 2016. GENOME MED 8(1):23. Read More […]

Published by

Integral Molecular Expands Intellectual Property Landscape with International Patents Protecting Key Lipoparticle technology

Integral Molecular, a leader in membrane protein antibody discovery, has announced the issuance of two key patents in Europe and the U.S., strengthening the […]

Published by

DNA Immunization Expert Dr. Ross Chambers Joins Integral Molecular to Lead Antibody Discovery

Integral Molecular, a leader in membrane protein antibody discovery, announced today the appointment of DNA immunization expert Ross Chambers, Ph.D., as Director of Antibody […]

Published by

Integral Molecular Identifies Key Molecular Interactions Responsible for the Effectiveness of the ZMapp™ Anti-Ebola Virus Cocktail

To support the creation of Ebola virus vaccines and treatments, Integral Molecular, a leader in membrane protein antibody discovery, has identified the key molecular […]

Published by

Cryo-EM structures Elucidate Neutralizing Mechanisms of anti-Chikungunya Human Monoclonal Antibodies with Therapeutic Activity.

LONG ET AL. 2015. PNAS 112(45):13898-13903. Read More […]

Published by

Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.

FOX ET AL. 2015. CELL 163(5):1095-1107. Read More […]

Published by

Integral Molecular Awarded $5.5M by the National Institutes of Health to Study Ebola Antibodies to Aid in Vaccine Discovery

With a new $5.5M award from the National Institute of Allergy and Infectious Diseases (NIAID) part of the National Institutes of Health (NIH), Integral […]

Published by

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.

SMITH ET AL. 2015. CELL HOST MICROBE 18(1):86-95. Read More […]

Published by

Cat Got Your Tongue? Not According to New Research

The ability to detect bitter chemicals is thought to have evolved because it helps animals avoid toxic compounds often found in plants. All cats, […]

Author: admin

Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response

Integral Molecular Expands Intellectual Property Landscape with International Patents Protecting Key Lipoparticle technology

DNA Immunization Expert Dr. Ross Chambers Joins Integral Molecular to Lead Antibody Discovery

Integral Molecular Identifies Key Molecular Interactions Responsible for the Effectiveness of the ZMapp™ Anti-Ebola Virus Cocktail

Cryo-EM structures Elucidate Neutralizing Mechanisms of anti-Chikungunya Human Monoclonal Antibodies with Therapeutic Activity.

Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.

Integral Molecular Awarded $5.5M by the National Institutes of Health to Study Ebola Antibodies to Aid in Vaccine Discovery

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.

Cat Got Your Tongue? Not According to New Research

Quick Links

Solutions

Contact Us